Hyung Sik Kim, Ph.D., Professor of Division of Toxicology, College of Pharmacy, Sungkyunkwan University, South Korea. He received M.S.in Feb. 25, 1991 from the College of Pharmacy, Sungkyunkwan University, Korea. He came to Dr. Byung Mu Lee’s Lab upon finishing graduate courses at College of Pharmacy, Sungkyunkwan University. He spent five years in this Lab during Ph.D. courses. He observed the correlation between chemical carcinogenesis and DNA-adduct formation during his Ph.D. period. He did excellent work during his graduate research by applying his analytical expertise to the studies on the cancer chemopreventive effects of plant polysaccharides on biomarkers associated with multistage carcinogenesis. In addition, He was experienced various techniques of molecular oncology. After He was awarded Ph.D. degree, He went to Korea Food & Drug Administration, and has served as a Senior Researcher thereafter. He has been involved in the adverse effect of Reproductive and Developmental toxicants. From 2003, He has been work as an Assistance Professor in the Division of Toxicology, College of Pharmacy, Pusan National University, Korea. He was a member of the American Association for Cancer Research (AACR), Society of Toxicology (SOT), International Congress of Toxicology (ICT), and Korean Society of Toxicology (KSOT). He also served as a vice president of 2013 International Congress of Toxicology (ICT), held in Seoul, Korea. Prof. Kim was the vice president of the 8th Asian Toxicology, held in Jeju, South Korea in 2015. He has contributed a great deal both to pharmacology, oncology and toxicology. His primary research areas of interest including identification of new cancer biomarker, mechanism study of new anticancer agents, cancer chemoprevention. He was involved as an author of several books including Encyclopedia of Environmental Health, Reproductive and Developmental Toxicology, Endocrine Disruptors etc. He is currently Editorial Board Member of the Journal Toxicology & Environmental Health Part A, Associate Editor of The Journal of Toxicological Sciences, and Editorial board members of Toxicological Research. He published 200 papers have been of enormous value to scientists working with various pharmacology and toxicological research.

Identification of new cancer biomarker, mechanism study of new anticancer agents, cancer chemoprevention.